Maryam Dadar, DVM, PhD, is currently a researcher at the Veterinary Council of Iran, Tehran, Iran. She s an Assistant Professor in the Department of Brucellosis at the Razi Vaccine and Serum Research Institute in Iran. Her extensive expertise lies in the field of microbiology and molecular biology, with main areas of research in zoonotic diseases, microbial risk assessments, Brucellosis prevention and control, and One Health. She has published articles in numerous international journals, edited books including an Elsevier title on brucellosis, and serves as an editor and is on the editorial board of a number of journals such as Microbial Risk Analysis (Elsevier). Dr. Dadar actively participates in international, multidisciplinary research collaborations with colleagues in Germany, United Kingdom, United States, and Pakistan and in educational initiatives aimed at advancing the scientific foundations of zoonotic infections, veterinary science, and molecular medicine.

• 1. Historical context and background ofbrucellosis in the world2. Brucellosis throughout human history3. The genetic diversity of Brucella speciesPart II Pathogenesis and immunobiology of brucellosis4. Pathogenesis and immunopathological phenomena around Brucella infections 5. Immunopathology in osteoarticular Brucella infection Part IIIBrucellosis in animals6. Brucellosis in livestock and companion animals7. Brucellosis in dogs: epidemiology, diagnosis, and public health concerns8. Brucellosis in aquatic mammals Part IVZoonotic transmission10. Occupational exposure to Brucella spp. and risk behaviors in exposed professions11. Brucellosis in Tanzania and Rwanda: Current status, challenges, and control strategiesPart V Diagnostic tools and techniques12. Diagnostic tools and techniques for Brucella detection13. Pathology of brucellosis in livestock Part VI Clinical manifestations in humans14. Brucellosis: Clinical manifestations in humans15. Rare cases of human brucellosisPart VII Prevention and control in animals16. The science of brucellosis elimination 17. Brucellosis control, eradication, and prevention 18. Comprehensive strategies for brucellosis control in endemic areas19. Efficacy of Brucella vaccine strains: S19, RB51, and Rev-1Part VIII Prevention and control in humans20. Therapeutic advances in human brucellosis21. Medicinal plants used in the treatment of brucellosisPart IX One health approach22. Knowledge, attitudes, and practices (KAP) relating to brucellosis: Unveiling the vital role of public awareness23. One health approach to brucellosis in SE Europe Part X Emerging trends and future prospects24. Challenges posed by antibiotic resistance in human and animal brucellosis25. Antimicrobial resistance of Brucella melitensis Part XI Brucellosis in food safety and processing26. Brucellosis in food safety

Maryam Dadar, DVM, PhD, is currently a researcher at the Veterinary Council of Iran, Tehran, Iran. She s an Assistant Professor in the Department of Brucellosis at the Razi Vaccine and Serum Research Institute in Iran. Her extensive expertise lies in the field of microbiology and molecular biology, with main areas of research in zoonotic diseases, microbial risk assessments, Brucellosis prevention and control, and One Health. She has published articles in numerous international journals, edited books including an Elsevier title on brucellosis, and serves as an editor and is on the editorial board of a number of journals such as Microbial Risk Analysis (Elsevier). Dr. Dadar actively participates in international, multidisciplinary research collaborations with colleagues in Germany, United Kingdom, United States, and Pakistan and in educational initiatives aimed at advancing the scientific foundations of zoonotic infections, veterinary science, and molecular medicine.

• 1. Historical context and background ofbrucellosis in the world2. Brucellosis throughout human history3. The genetic diversity of Brucella speciesPart II Pathogenesis and immunobiology of brucellosis4. Pathogenesis and immunopathological phenomena around Brucella infections 5. Immunopathology in osteoarticular Brucella infection Part IIIBrucellosis in animals6. Brucellosis in livestock and companion animals7. Brucellosis in dogs: epidemiology, diagnosis, and public health concerns8. Brucellosis in aquatic mammals Part IVZoonotic transmission10. Occupational exposure to Brucella spp. and risk behaviors in exposed professions11. Brucellosis in Tanzania and Rwanda: Current status, challenges, and control strategiesPart V Diagnostic tools and techniques12. Diagnostic tools and techniques for Brucella detection13. Pathology of brucellosis in livestock Part VI Clinical manifestations in humans14. Brucellosis: Clinical manifestations in humans15. Rare cases of human brucellosisPart VII Prevention and control in animals16. The science of brucellosis elimination 17. Brucellosis control, eradication, and prevention 18. Comprehensive strategies for brucellosis control in endemic areas19. Efficacy of Brucella vaccine strains: S19, RB51, and Rev-1Part VIII Prevention and control in humans20. Therapeutic advances in human brucellosis21. Medicinal plants used in the treatment of brucellosisPart IX One health approach22. Knowledge, attitudes, and practices (KAP) relating to brucellosis: Unveiling the vital role of public awareness23. One health approach to brucellosis in SE Europe Part X Emerging trends and future prospects24. Challenges posed by antibiotic resistance in human and animal brucellosis25. Antimicrobial resistance of Brucella melitensis Part XI Brucellosis in food safety and processing26. Brucellosis in food safety

Maryam Dadar, DVM, PhD, is currently a researcher at the Veterinary Council of Iran, Tehran, Iran. She s an Assistant Professor in the Department of Brucellosis at the Razi Vaccine and Serum Research Institute in Iran. Her extensive expertise lies in the field of microbiology and molecular biology, with main areas of research in zoonotic diseases, microbial risk assessments, Brucellosis prevention and control, and One Health. She has published articles in numerous international journals, edited books including an Elsevier title on brucellosis, and serves as an editor and is on the editorial board of a number of journals such as Microbial Risk Analysis (Elsevier). Dr. Dadar actively participates in international, multidisciplinary research collaborations with colleagues in Germany, United Kingdom, United States, and Pakistan and in educational initiatives aimed at advancing the scientific foundations of zoonotic infections, veterinary science, and molecular medicine.

• 1. Historical context and background ofbrucellosis in the world2. Brucellosis throughout human history3. The genetic diversity of Brucella speciesPart II Pathogenesis and immunobiology of brucellosis4. Pathogenesis and immunopathological phenomena around Brucella infections 5. Immunopathology in osteoarticular Brucella infection Part IIIBrucellosis in animals6. Brucellosis in livestock and companion animals7. Brucellosis in dogs: epidemiology, diagnosis, and public health concerns8. Brucellosis in aquatic mammals Part IVZoonotic transmission10. Occupational exposure to Brucella spp. and risk behaviors in exposed professions11. Brucellosis in Tanzania and Rwanda: Current status, challenges, and control strategiesPart V Diagnostic tools and techniques12. Diagnostic tools and techniques for Brucella detection13. Pathology of brucellosis in livestock Part VI Clinical manifestations in humans14. Brucellosis: Clinical manifestations in humans15. Rare cases of human brucellosisPart VII Prevention and control in animals16. The science of brucellosis elimination 17. Brucellosis control, eradication, and prevention 18. Comprehensive strategies for brucellosis control in endemic areas19. Efficacy of Brucella vaccine strains: S19, RB51, and Rev-1Part VIII Prevention and control in humans20. Therapeutic advances in human brucellosis21. Medicinal plants used in the treatment of brucellosisPart IX One health approach22. Knowledge, attitudes, and practices (KAP) relating to brucellosis: Unveiling the vital role of public awareness23. One health approach to brucellosis in SE Europe Part X Emerging trends and future prospects24. Challenges posed by antibiotic resistance in human and animal brucellosis25. Antimicrobial resistance of Brucella melitensis Part XI Brucellosis in food safety and processing26. Brucellosis in food safety